Protective Effects of Topiramate against Hyperoxic Brain Injury in the Developing Brain

Abstract

Recent studies have shown that exposure to hyperoxia in infant rats leads to extensive apoptotic degeneration in the cortex and white matter of the developing brain. Besides its antiepileptic effects, topiramate exerts neuroprotective effects in animal models of stroke, hypoxia ischemia, excitotoxic insults, and status epilepticus. In the present study, we investigated the effects of topiramate against hyperoxia-induced neurodegeneration in the developing brain. Eighteen Wistar rat pups were divided into three groups: control group, hyperoxia+phosphate buffered saline treated group and hyperoxia+topiramate treated group. Hyperoxia groups were exposed to 80% oxygen (n=12) in plexiglas chambers in which the oxygen concentration was monitored twice daily from birth until postnatal day five. The hyperoxia+topiramate group received an intraperitoneal injection of topiramate at a dose of 80 mg/kg/day. At postnatal day 5, all animals were killed. Neuronal cell death and apoptosis were evaluated. Histopathological examination showed that topiramate significantly diminished apoptosis in the CA1 region and dentate gyrus of hippocampus. Topiramate may offer a therapeutic potential for neuroprotection under conditions of hyperoxic brain injury.

Key words

apoptosis - brain - hyperoxia - newborn - rat - topiramate

References

• 1 Arkovitz MS, Szabo C, Garcia VF. et al . Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung.  Shock. 1997;  7 345-350
• 2 Cha HB, Silveria CD, Liu X. et al . Effect of topiramate following recurrent and prolonged seizures during early development.  Epi Res. 2002;  51 217-232
• 3 Chen X, Bao G, Hua Y. et al . The effects of topiramate on caspase-3 expression in hippocampus of basolateral amygdala (BLA) electrical kindled epilepsy rat.  J Mol Neurosci. 2009;  , epub ahead of print
• 4 Dobbing J, Sands J, Gratrix CA. Cell size and cell number: a reconsideration of organ growth and catch-up potential.  Proc Nutr Soc. 1979;  38 99A
• 5 Felderhoff-Mueser U, Bittigau P, Sifringer M. et al . Oxygen causes cell death in the developing brain.  Neurobiol Dis. 2004;  17 273-282
• 6 Felderhoff-Mueser U, Sifringer M, Polley O. et al . Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain.  Ann Neurol. 2005;  57 50-59
• 7 Follett PL, Deng W, Dai W. et al . Glutamate receptor-mediated oligodendrocyte toxity in periventricular leukomalacia: a protective role for topiramate.  J Neurosci. 2004;  24 4412-4420
• 8 Gerdin E, Tyden O, Eriksson UJ. The development of antioxidant enzymatic defense in the perinatal rat lung: activities of superoxide dismutase, glutathione peroxidase, and catalase.  Pediatr Res. 1985;  19 687-691
• 9 Gerstner B, DeSilva TM, Genz K. et al . Hyperoxia causes maturation-dependent cell death in the developing white matter.  J Neurosci. 2008;  28 1236-1245
• 10 Gibbs JW, Sombati S, DeLorenzo RJ. et al . Cellular actions of topiramate: blockade of kainate-evoked inward currents incultured hippocampal neurons.  Epilepsia. 2000;  41 10-16
• 11 Glier C, Dzietko M, Bittigau P. et al . Therapeutic doses of topiramate are not toxic to the developing rat brain.  Exp Neurol. 2004;  187 403-409
• 12 Haugvicova R, KubovaŽ H, Skutova M. et al . Anticonvulsant action of topiramate against motor seizures in developing rats.  Epilepsia. 2000;  41 1235-1240
• 13 Hintz SR, Kendrick DE, Vohr BR. et al . Changes in neurodevelopmental outcomes at 18 to 22 months corrected age among infants of less than 25 weeks gestational age born in 1993 – 1999.  Pediatrics. 2005;  115 1645-1651
• 14 Hu X, Qiu J, Grafe MR. et al . Bcl-2 family members make different contributions to cell death in hypoxia and/or hyperoxia in rat cerebral cortex.  Int J Dev Neurosci. 2003;  21 371-377
• 15 Ikonomidou C, Bosch F, Miksa M. et al . Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.  Science. 1999;  283 70-74
• 16 Ishikawa Y, Satoh T, Enokido Y. et al . Generation of reactive oxygen species, release of L-glutamate and activation of caspases are required for oxygen induced apoptosis of embryonic hippocampal neurons in culture.  Brain Res. 1999;  824 71-80
• 17 Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients.  Epilepsy Res. 2003;  54 171-178
• 18 Koch JD, Miles DK, Gilley JA. et al . Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury.  J Cereb Blood Flow Metab. 2008;  28 1294-1306
• 19 Liu Y, Barks JD, Xu G. et al . Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats.  Stroke. 2004;  35 1460-1465
• 20 Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus.  Brain Res. 1999;  837 263-269
• 21 Noh MR, Kim SK, Sun W. et al . Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats.  Exp Neurol. 2007;  203 5-7
• 22 Park HJ, Kim HJ, Ra J. et al . Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus.  Epilepsia. 2008;  49 163-167
• 23 Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug.  Parmacol Res. 1997;  35 241-256
• 24 Rosen GD, Williams AG, Capra JA. et al . The Mouse Brain.  , Library 2000, available from: http://www.mbl.org
• 25 Rosenfeld WE. Topiramate: a review of preclinical, pharmacokinetic, and clinical data.  Clin Ther. 1997;  19 1294-1308
• 26 Schneiderman JH. Topiramate: pharmacokinetics and pharmacodynamics.  Can J Neurol Sci. 1998;  25 3-5
• 27 Schubert S, Brandl U, Brodhun M. et al . Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets.  Brain Res. 2005;  1058 129-136
• 28 Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.  J Clin Invest. 2001;  107 717-725
• 29 Sfaello I, Baud O, Arzimanoglou A. et al . Topiramate prevents excitotoxic damage in the newborn rodent brain.  Neurobiol Dis. 2005;  20 837-848
• 30 Shank RP, Gardocki JF, Vaught JL. et al . Topiramate: preclinical evaluation of structurally novel anticonvulsant.  Epilepsia. 1994;  35 450-460
• 31 Sirinyan M, Sennlaub F, Dorfman A. et al . Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject.  Stroke. 2006;  37 2807-2815
• 32 Sola A, Rogido MR, Deulofeut R. Oxygen as a neonatal health hazard: call for détente in clinical practice.  Acta Paediatr. 2007;  96 801-812
• 33 White HS, Brown SD, Woodhead JH. et al . Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.  Epilepsy Res. 1997;  28 167-179
• 34 Willmore LJ. Antiepileptic drugs and neuroprotection: current status and future roles.  Epilepsy Behav. 2005;  7 25-28
• 35 Yis U, Kurul SH, Kumral A. et al . Hyperoxic exposure leads to cell death in the developing brain.  Brain Dev. 2008;  30 556-562

Correspondence